Metagenomi, Inc.
MGX
$2.07
$0.136.70%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -42.45% | 79.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -42.45% | 79.30% | |||
| Cost of Revenue | -7.29% | -9.92% | |||
| Gross Profit | -77.36% | 59.01% | |||
| SG&A Expenses | -10.64% | -2.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.07% | -8.26% | |||
| Operating Income | -32.73% | 41.92% | |||
| Income Before Tax | -61.38% | 48.55% | |||
| Income Tax Expenses | 4.23% | -- | |||
| Earnings from Continuing Operations | -74.81% | 57.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -74.81% | 57.30% | |||
| EBIT | -32.73% | 41.92% | |||
| EBITDA | -35.14% | 43.97% | |||
| EPS Basic | -74.15% | 75.36% | |||
| Normalized Basic EPS | -44.93% | 70.31% | |||
| EPS Diluted | -74.15% | 75.36% | |||
| Normalized Diluted EPS | -44.93% | 70.31% | |||
| Average Basic Shares Outstanding | 0.38% | 73.27% | |||
| Average Diluted Shares Outstanding | 0.38% | 73.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
